Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Suppression of Hepatocellular Carcinoma Progression through FOXM1 and EMT Inhibition via Hydroxygenkwanin-Induced miR-320a Expression
Li‐Fang Chou, Chi‐Yuan Chen, Wan-Hua Yang, et al.
Biomolecules (2019) Vol. 10, Iss. 1, pp. 20-20
Open Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Recent progress in treatment of hepatocellular carcinoma.
Zhiqian Chen, Hao Xie, Mingming Hu, et al.
PubMed (2020) Vol. 10, Iss. 9, pp. 2993-3036
Closed Access | Times Cited: 253
Natural Coumarins: Exploring the Pharmacological Complexity and Underlying Molecular Mechanisms
Javad Sharifi‐Rad, Natália Martins, Pía López‐Jornet, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 162
SirT3 activates AMPK-related mitochondrial biogenesis and ameliorates sepsis-induced myocardial injury
Ting Xin, Chengzhi Lu
Aging (2020) Vol. 12, Iss. 16, pp. 16224-16237
Open Access | Times Cited: 124
Traditional Chinese medicine for prevention and treatment of hepatocellular carcinoma: A focus on epithelial-mesenchymal transition
Jiajia Li, Qing Liang, Guangchun Sun
Journal of Integrative Medicine (2021) Vol. 19, Iss. 6, pp. 469-477
Closed Access | Times Cited: 49
Harnessing function of EMT in hepatocellular carcinoma: From biological view to nanotechnological standpoint
Yaser E. Alqurashi, Hussein Riyadh Abdul Kareem Al‐Hetty, Pushpamala Ramaiah, et al.
Environmental Research (2023) Vol. 227, pp. 115683-115683
Closed Access | Times Cited: 14
MicroRNA 320, an Anti-Oncogene Target miRNA for Cancer Therapy
Yuan-Yuan Liang, Shun Li, Liling Tang
Biomedicines (2021) Vol. 9, Iss. 6, pp. 591-591
Open Access | Times Cited: 37
Melatonin Sensitizes Hepatocellular Carcinoma Cells to Chemotherapy Through Long Non-Coding RNA RAD51-AS1-Mediated Suppression of DNA Repair
Chih‐Cheng Chen, Chi‐Yuan Chen, Shu‐Huei Wang, et al.
Cancers (2018) Vol. 10, Iss. 9, pp. 320-320
Open Access | Times Cited: 44
Fibrogenic signals persist in DAA-treated HCV patients after sustained virological response
Claudia Montaldo, Michela Terri, Veronica Riccioni, et al.
Journal of Hepatology (2021) Vol. 75, Iss. 6, pp. 1301-1311
Open Access | Times Cited: 30
Hydroxygenkwanin Suppresses Non-Small Cell Lung Cancer Progression by Enhancing EGFR Degradation
Yann-Lii Leu, Tong‐Hong Wang, Chih‐Ching Wu, et al.
Molecules (2020) Vol. 25, Iss. 4, pp. 941-941
Open Access | Times Cited: 27
Total Flavonoids in Artemisia absinthium L. and Evaluation of Its Anticancer Activity
Meizhu He, Kamarya Yasin, Shaoqi Yu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 22, pp. 16348-16348
Open Access | Times Cited: 9
Daphne genkwa: Ethnopharmacology, phytochemistry and pharmacology of an important traditional Chinese medicine
Yue Hu, Rongrong Pan, Yi Wang, et al.
Fitoterapia (2024) Vol. 177, pp. 106089-106089
Closed Access | Times Cited: 2
Maternal exposure to Di-n-butyl phthalate (DBP) aggravate gestational diabetes mellitus via FoxM1 suppression by pSTAT1 signalling
Min Chen, Sheng Zhao, Wenhuan Guo, et al.
Ecotoxicology and Environmental Safety (2020) Vol. 205, pp. 111154-111154
Open Access | Times Cited: 23
Bioactive Compounds as Potential Agents for Sexually Transmitted Diseases Management: A Review to Explore Molecular Mechanisms of Action
Javad Sharifi‐Rad, Cristina Quispe, Amirhossein Rahavian, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 21
FAT10 promotes chemotherapeutic resistance in pancreatic cancer by inducing epithelial-mesenchymal transition via stabilization of FOXM1 expression
Jinfeng Zhu, Jiefeng Zhao, Chen Luo, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 5
Open Access | Times Cited: 13
MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination
Hengzheng He, Jian Zhou, Fahui Cheng, et al.
Human Cell (2023) Vol. 36, Iss. 5, pp. 1773-1789
Closed Access | Times Cited: 7
Cost‐effectiveness of antiviral treatment after resection in hepatitis B virus–related hepatocellular carcinoma patients with compensated cirrhosis
Li Xie, Juan Yin, Ruyi Xia, et al.
Hepatology (2018) Vol. 68, Iss. 4, pp. 1476-1486
Closed Access | Times Cited: 24
LINC00460 Promotes Cell Proliferation, Migration, Invasion, and Epithelial-Mesenchymal Transition of Head and Neck Squamous Cell Carcinoma via miR-320a/BGN Axis
Yifan Yang, Ru Wang, Feng Ling, et al.
OncoTargets and Therapy (2021) Vol. Volume 14, pp. 2279-2291
Open Access | Times Cited: 17
Total flavonoids in Artemisia absinthium L. and evaluation of its anticancer activity
Meizhu He, Kamarya Yasin, Zihang Ma, et al.
Research Square (Research Square) (2023)
Open Access | Times Cited: 5
Hydroxygenkwanin Inhibits Class I HDAC Expression and Synergistically Enhances the Antitumor Activity of Sorafenib in Liver Cancer Cells
Chi‐Yuan Chen, Chih‐Cheng Chen, Wen‐Yu Chuang, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 15
Participation of MicroRNAs in the Treatment of Cancer with Phytochemicals
Seung Wan Son, Han Yeoung Lee, Sokviseth Moeng, et al.
Molecules (2020) Vol. 25, Iss. 20, pp. 4701-4701
Open Access | Times Cited: 15
miR-320a/SP1 negative reciprocal interaction contributes to cell growth and invasion in colorectal cancer
Wenjing Zhang, Haitao Yang, Zhongqiu Wang, et al.
Cancer Cell International (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 11
A holistic comparison of flavor signature and chemical profile in different harvesting periods of Chrysanthemum morifolium Ramat. based on metabolomics combined with bioinformatics and molecular docking strategy
Mengxin Yang, Xi Tian, Miaoting Zhang, et al.
RSC Advances (2022) Vol. 12, Iss. 54, pp. 34971-34989
Open Access | Times Cited: 8
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1
Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 10
Long non‑coding RNA XIST accelerates hepatic carcinoma progression by targeting the microRNA‑320a/PIK3CA axis
Lina Yang, Fang-Liang Xie, Weidong Xu, et al.
Oncology Letters (2021) Vol. 22, Iss. 5
Open Access | Times Cited: 9
Roles of conventional and complementary therapies in recurrent hepatocellular carcinoma
Hsiang-Chun Lai, Hung‐Jen Lin, Long‐Bin Jeng, et al.
World Journal of Gastrointestinal Oncology (2023) Vol. 15, Iss. 1, pp. 19-35
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top